8 research outputs found
Luteal phase support with GnRH agonist does not eliminate the risk for ovarian hyperstimulation syndrome
No full textAngiogenic cytokine and interleukin 8 levels in early luteal phase after triggering ovulation with gonadotropin‐releasing hormone agonist in high‐responder patients
No full textSuccessful pregnancy complicated by spontaneous, familial, recurrent ovarian hyperstimulation syndrome: report of two cases
No full text
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols
No full textThe original version of this article unfortunately contained a mistake. The middle initial of Douglas A. Mata was omitted. The original article has been corrected
